BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 22752548)

  • 1. Expression of bone morphogenetic protein-4 in the cortical lesions of focal cortical dysplasia IIb and the tuberous sclerosis complex.
    Guo W; Zhang CQ; Shu HF; Yang MH; Yin Q; Yang H
    J Mol Neurosci; 2013 May; 50(1):7-13. PubMed ID: 22752548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of leukocyte immunoglobulin-like receptor B2 signaling pathway in cortical lesions of pediatric patients with focal cortical dysplasia type IIb and tuberous sclerosis complex.
    Yue J; Zhang C; Shi X; Wei Y; Liu L; Liu S; Yang H
    Brain Dev; 2019 Nov; 41(10):829-838. PubMed ID: 31495513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered inhibition in tuberous sclerosis and type IIb cortical dysplasia.
    Talos DM; Sun H; Kosaras B; Joseph A; Folkerth RD; Poduri A; Madsen JR; Black PM; Jensen FE
    Ann Neurol; 2012 Apr; 71(4):539-51. PubMed ID: 22447678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Doublecortin-like (DCL) expression in focal cortical dysplasia and cortical tubers.
    Boer K; Lucassen PJ; Spliet WG; Vreugdenhil E; van Rijen PC; Troost D; Jansen FE; Aronica E
    Epilepsia; 2009 Dec; 50(12):2629-37. PubMed ID: 19583781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Downregulation of CD47 and CD200 in patients with focal cortical dysplasia type IIb and tuberous sclerosis complex.
    Sun FJ; Zhang CQ; Chen X; Wei YJ; Li S; Liu SY; Zang ZL; He JJ; Guo W; Yang H
    J Neuroinflammation; 2016 Apr; 13(1):85. PubMed ID: 27095555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased expression of matrix metalloproteinase 9 in cortical lesions from patients with focal cortical dysplasia type IIb and tuberous sclerosis complex.
    Li S; Yu S; Zhang C; Shu H; Liu S; An N; Yang M; Yin Q; Yang H
    Brain Res; 2012 May; 1453():46-55. PubMed ID: 22459050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of TRPV1 in cortical lesions from patients with tuberous sclerosis complex and focal cortical dysplasia type IIb.
    Shu HF; Yu SX; Zhang CQ; Liu SY; Wu KF; Zang ZL; Yang H; Zhou SW; Yin Q
    Brain Dev; 2013 Mar; 35(3):252-60. PubMed ID: 22647236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Expression of autophagy-related proteins in malformations of cortical development].
    Chen S; Piao Y; Fu Y; Li Z; Liu C; Lu D
    Zhonghua Bing Li Xue Za Zhi; 2015 May; 44(5):305-9. PubMed ID: 26178210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression patterns of synaptic vesicle protein 2A in focal cortical dysplasia and TSC-cortical tubers.
    Toering ST; Boer K; de Groot M; Troost D; Heimans JJ; Spliet WG; van Rijen PC; Jansen FE; Gorter JA; Reijneveld JC; Aronica E
    Epilepsia; 2009 Jun; 50(6):1409-18. PubMed ID: 19220410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cellular localization of metabotropic glutamate receptors in cortical tubers and subependymal giant cell tumors of tuberous sclerosis complex.
    Boer K; Troost D; Timmermans W; Gorter JA; Spliet WG; Nellist M; Jansen F; Aronica E
    Neuroscience; 2008 Sep; 156(1):203-15. PubMed ID: 18706978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression and cellular distribution of FGF13 in cortical tubers of the tuberous sclerosis complex.
    Wu K; Yue J; Shen K; He J; Zhu G; Liu S; Yang H; Zhang CQ
    Neurosci Lett; 2021 Apr; 749():135714. PubMed ID: 33582188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated Expression of TRPC4 in Cortical Lesions of Focal Cortical Dysplasia II and Tuberous Sclerosis Complex.
    Wang LK; Chen X; Zhang CQ; Liang C; Wei YJ; Yue J; Liu SY; Yang H
    J Mol Neurosci; 2017 Jun; 62(2):222-231. PubMed ID: 28455787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impaired oligodendroglial turnover is associated with myelin pathology in focal cortical dysplasia and tuberous sclerosis complex.
    Scholl T; Mühlebner A; Ricken G; Gruber V; Fabing A; Samueli S; Gröppel G; Dorfer C; Czech T; Hainfellner JA; Prabowo AS; Reinten RJ; Hoogendijk L; Anink JJ; Aronica E; Feucht M
    Brain Pathol; 2017 Nov; 27(6):770-780. PubMed ID: 27750396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of the Nogo-A system in cortical lesions of pediatric patients with tuberous sclerosis complex and focal cortical dysplasia type IIb.
    Yu SX; Li S; Shu HF; Zhang CQ; Liu SY; Yang H
    J Neuropathol Exp Neurol; 2012 Jul; 71(7):665-77. PubMed ID: 22710967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxidative stress and inflammation in a spectrum of epileptogenic cortical malformations: molecular insights into their interdependence.
    Arena A; Zimmer TS; van Scheppingen J; Korotkov A; Anink JJ; Mühlebner A; Jansen FE; van Hecke W; Spliet WG; van Rijen PC; Vezzani A; Baayen JC; Idema S; Iyer AM; Perluigi M; Mills JD; van Vliet EA; Aronica E
    Brain Pathol; 2019 May; 29(3):351-365. PubMed ID: 30303592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Down-regulated expression of acid-sensing ion channel 1a in cortical lesions of patients with focal cortical dysplasia.
    Guo W; Chen X; He JJ; Wei YJ; Zang ZL; Liu SY; Yang H; Zhang CQ
    J Mol Neurosci; 2014 Jun; 53(2):176-82. PubMed ID: 24682892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression patterns of glial fibrillary acidic protein (GFAP)-delta in epilepsy-associated lesional pathologies.
    Martinian L; Boer K; Middeldorp J; Hol EM; Sisodiya SM; Squier W; Aronica E; Thom M
    Neuropathol Appl Neurobiol; 2009 Aug; 35(4):394-405. PubMed ID: 19508443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Downregulated formyl peptide receptor 2 expression in the epileptogenic foci of patients with focal cortical dysplasia type IIb and tuberous sclerosis complex.
    Huang K; Wang Z; He Z; Li Y; Li S; Shen K; Zhu G; Liu Z; Lv S; Zhang C; Yang H; Yang X; Liu S
    Immun Inflamm Dis; 2022 Nov; 10(11):e706. PubMed ID: 36301030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemical expression of fibroblast growth factor (FGF)-2 in epilepsy-associated malformations of cortical development (MCDs).
    Sugiura C; Miyata H; Ueda M; Ohama E; Vinters HV; Ohno K
    Neuropathology; 2008 Aug; 28(4):372-81. PubMed ID: 18179408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Downregulated GPR30 expression in the epileptogenic foci of female patients with focal cortical dysplasia type IIb and tuberous sclerosis complex is correlated with
    Wang Z; Huang K; Yang X; Shen K; Yang L; Ruan R; Shi X; Wang M; Zhu G; Yang M; Zhang C; Lv S; Yang H; Fan X; Liu S
    Brain Pathol; 2021 Mar; 31(2):346-364. PubMed ID: 33314369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.